Роль транскрипционного фактора, чувствительного к гипоксии, hypoxia-inducible factor-1 в опухолевой прогрессии при раке слизистой оболочки полости рта

 In the literary review, summarized the results of large randomized controlled trials on the impact factor, sensitive to hypoxia-1, in the development of cancer of the oral mucosa and its progression.

фактор, чувствительный к гипоксии, рак слизистой оболочки полости рта, рецидивирование, метастазирование.

hypoxia-inducible factor-1, oral squamous cell сarcinoma, recurrence, metastasis.

1. Серебровская Т.В. Гипоксия-индуцибельный фактор: роль в патофизиологии дыхания (обзор) // Украинский пульмонологический журнал. - 2005. - №3. - С. 77-81.

2. Bock J.M., Sinclair L.L., Bedford N.S., Jackson R.E., Lee J.H.,Trask D.K. Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck // Arch Otolaryngol Head Neck Surg. -  2008. - Vol.134. - P. 355-362.

3. Brennan P.A., Mackenzie N., Quintero M. Hypoxiainducible factor 1α in oral cancer // J Oral Pathol Med. - 2005. - Vol.34. - P. 385-389.

4. De Lima P.O., Jorge C.C., Oliveira D.T., Pereira M.C. Hypoxic condition and prognosis in oral squamous cell carcinoma // Anticancer research. - 2014. - Vol.34. - P. 605-612.

5. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour // Nat Rev Cancer. - 2008. - Vol. 8. - P. 705-713.

6. Eckert A.W., Kappler M., Schubert J., Taubert H. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients // Oral Maxillofac Surg. - 2012. - Vol.16. - P. 189-196.

7. Eckert A.W., Lautner M.H., Schutze A., Bolte K. et al. Co-expression of HIF1α and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients // J Oral Pathol Med. - 2010. - Vol.39. - P. 313-317.

8. Eckert A.W., Lautner M.H., Schutze A., Taubert H. et al. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients // Histopathology. - 2011. - Vol.58. - P. 1136-1147.

9. Fillies T., Werkmeister R., van Diest P.J., Brandt B. et al. HIF1-α overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor // BMC Cancer. - 2005. - Vol. 5. - P. 84.

10. Flamme I., Frohlich T., von Reutern M., Kappel A., Damert A., Risau W. HRF, a putative basic helixloop- helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels // Mech Dev. - 1997. -Vol. 63 (1). - P. 51-60.

11. Gu Y.Z., Hogenesch J. B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals // Annu. Rev. Pharmacol. Toxicol. - 2000. - Vol. 40. - P. 519-561.

12. Hewitson K.S., McNeill L A., Riordan M.V., Tian Y.M. et al. Hypoxia- inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family // J.Biol. Chem. - 2002. - Vol. 277. - P. 26351-26355.

13. Huang C., Sun Z., Sun Y., Chen X. et al. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma // Histopathology. - 2012. - Vol. 60. - P. 793-803.

14. Jiang J., Tang Y.L., Liang X.H. A new vision of hypoxia promoting cancer progression // Cancer Biol Ther. - 2011. - Vol. 11. - P. 714-723.

15. Kang F.W., Gao Y., Que L., Sun J., Wang Z.L. Hypoxiainducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma // Exp Ther Med. - 2013. - Vol. 5. - P. 112-118.

16. Kim S.Y., Nam S.Y., Choi S.H., Cho K.J., Roh J.L. Prognostic value of lymph node density in nodepositive patients with oral squamous cell carcinoma // Ann Surg Oncol. - 2011. - Vol.18. - P. 2310-2317.

17. Lando D., Gorman J.J., Whitelaw M.L., Peet D.J. Oxygen - dependent regulation of hypoxia – inducible factors by prolyl and asparaginyl hydroxylation // Eur J Biochem. - 2003 - Vol. 270(5). - P. 781-790.

18. Lando D., Peet, D. J., Whelan, D. A., Gorman, J. J. and White& law, M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch // Science. - 2002. - Vol. 295. - P. 858-861.

19. Liang X.H., Zheng M., Jiang J.A., Zhu G.Q., Yang J., Tang Y.L. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma // Oral Oncol. - 2011. - Vol. 47. - P. 92-97.

20. Liehara K.T., Lien J.C., Chung C.H., Kuo S.C., Huang T.F. Bp5250 inhibits vascular endothelial growth factorinduced angiogenesis and HIF-1α expression on endothelial cells. Naunyn Schmiedebergs // Arch Pharmacol. - 2012. - Vol. 385. - P. 39-49.

21. Lin P.Y., Yu C.H., Wang J.T., Chen H.H., Cheng S.J., Kuo M.Y., Chiang C.P. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan // J Oral Pathol Med. - 2008. - Vol. 37. - P. 18-25.

22. Masson N., Ratcliffe P.J. HIF prolyl and asparaginyl hyroxylases in the biological response to intracellular O2 levels // J. Cell Sci. - 2003. - Vol. 116 - P. 3041-3049.

23. Ministerio da Saude, Instituto Nacional de Cancer: Cancer da cavidade oral. In: Estimativa 2012: Incidencia de Cancer no Brasil. Rio de Janeiro: Instituto Nacional de Cancer, pp. 40-41, 2011.

24. Mohamed K.M., Le A., Duong H., Wu Y., Zhang Q., Messadi D.V. Correlation between VEGF and HIF-1α expression in human oral squamous cell carcinoma // Exp Mol Pathol. - 2004. - Vol. 76. - P. 143-152.

25. Ryu M.H., Park H.M., Chung J., Lee C.H., Park H.R. Hypoxiainducible factor-1α mediates oral squamous cell carcinoma invasion via up-regulation of α5 integrin and fibronectin. // Biochem Biophys Res Commun. - 2010. - Vol. 393. - P. 11-15.

26. Semenza G.L. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology // Annu Rev Pathol. - 2013. - Vol. 7. - P. 7.

27. Santos M., Mercante A.M., Louro I.D., Goncalves A.J., de Carvalho M.B., da Silva E.H., da Silva A.M. HIF1α expression predicts survival of patients with squamous cell carcinoma of the oral cavity // PLoS One. - 2012. - Vol. 7. - P. 18.

28. Shang Z.J., Li J.R., Li Z.B. Up-regulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma // J Oral Maxillofac Surg. - 2007. - Vol. 65. - P. 17-21.

29. Shang Z.J., Li Z.B., Li J.R. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: In vitro and in vivo studies.// Int J Oral Maxillofac Surg. - 2006. - Vol. 35. - P. 533-538.

30. Soengas M.S., Alarcon R.M., Yoshida H., Giaccia A.J., Hakem R., Mak T.W., Lowe S.W. APAF1 and caspase-9 in p53-dependent apoptosis and tumor inhibition // Science. - 1999. - Vol. 284. - P. 156-159.

31. Uchida T., Rossignol F., Matthay M. A, Mounier R., Couette S., Clottes E., Clerici C. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)- 1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha // J.Biol Chem. - 2004. - Vol. 279 (15). - P. 14871-14878.

32. Wang G.L., Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction // Blood. - 1993. - Vol. 82. - P. 3610-3615.

33. Weinberg R.A. The Biology of Cancer. - 2014. Garland Science. - 231 p.

34. World Health Organization: International Classification of Diseases. - Geneva, 2007.